News

A breakthrough in the understanding of the relationship between a naturally occurring enzyme and the liver cancer drug sorafenib could improve the effectiveness of the drug.

Two new studies led by researchers from the UCLA Jonsson Comprehensive Cancer Center give insight into how cells use energy to influence the way prostate tumors survive and grow.

Aspirin is inexpensive and readily available in almost every country. According to a meta-analysis, taking a daily low dose (75 or 81 mg/day) of aspirin was associated with a 20% reduction in deaths from cancer and in deaths from all causes.

Researchers reviewed nationwide data encompassing more than 200,000 individuals from diverse racial and ethnic backgrounds to assess the role of genetics in the sex differences in hypertension in a recent study.

A new study found Black men diagnosed with more advanced stages of prostate cancer are significantly less likely to be prescribed novel hormone therapy than other racial and ethnic groups.

Combining a pair of experimental drugs may help treat malignant peripheral nerve sheath tumors with fewer harmful side effects, according to preliminary animal studies.

Researchers at the Dana-Farber Cancer Institute have developed a promising new drug candidate, EAI-432, to treat drug-resistant non-small cell lung cancers.

The findings of a new study suggest that increasing the intake of folate – which can be found in leafy greens, such as spinach, cabbage and broccoli – could help to reduce the risk of colorectal cancer by up to 7%.

According to research, inhibiting the galectin 1 protein, which is often over-expressed in hepatocellular carcinoma (HCC) using gene therapy can shrink HCC and increase the number of killer T cells inside tumors in mice.

Incorporating navy beans into the diet of colorectal cancer patients may boost gut health and the health of the patient by modulating obesity and disease-linked markers.